Pharmabiz

Indian scientist brings research study on essential oils done at Glasgow a century ago for medicinal use

Indian scientist brings research study on essential oils done at Glasgow a century ago for medicinal use: Shardul Nautiyal, Mumbai Monday, September 21, 2026, 13:40 Hrs [IST] An I ...
Pharmabiz

Chugai obtains Japanese approval for FoundationOne CDx Cancer Genomic Profile as a companion diagnostic of lorlatinib for ALK fusion gene-positive NSCLC

Chugai obtains Japanese approval for FoundationOne CDx Cancer Genomic Profile as a companion diagnostic of lorlatinib for ALK fusion gene-positive NSCLC: Tokyo Monday, September 2 ...
Pharmabiz

mAbxience and Sandoz ink collaboration agreement to advance biosimilar access worldwide

Abxience and Sandoz ink collaboration agreement to advance biosimilar access worldwide: Madrid, Spain Monday, September 21, 2026, 13:00 Hrs [IST] mAbxience, a majority-owned comp ...
Pharmabiz

Sagility India enters Asia’s top 60 best workplaces, ranked 57 in 2026 by Great Place to Work

Sagility India enters Asia’s top 60 best workplaces, ranked 57 in 2026 by Great Place to Work: Our Bureau Bengaluru Monday, September 21, 2026, 17:45 Hrs [IST] Sagility India, a ...
Pharmabiz

AstraZeneca & Daiichi Sankyo’s Enhertu recommended approval in EU as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early ...

AstraZeneca & Daiichi Sankyo’s Enhertu recommended approval in EU as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early br ...
Pharmabiz

Integrated care emerges as the next frontier in cancer treatment as women’s cancer burden rises

Integrated care emerges as the next frontier in cancer treatment as women’s cancer burden rises: Our Bureau, Mumbai Monday, September 21, 2026, 13:50 Hrs [IST] As the burden of ...
Pharmabiz

One in four doctors nearing retirement age as WHO warns of global health workforce gap

One in four doctors nearing retirement age as WHO warns of global health workforce gap: Geneva Monday, September 21, 2026, 17:00 Hrs [IST] The World Health Organization (WHO) has ...
Pharmabiz

Biocon’s pertuzumab becomes first biosimilar to secure EMA CHMP approval under new tailored clinical approach

Biocon’s pertuzumab becomes first biosimilar to secure EMA CHMP approval under new tailored clinical approach: Our Bureau, Bengaluru Monday, September 21, 2026, 13:15 Hrs [IST] ...
Pharmabiz

Andelyn and its curator platform achieve first US FDA-approved commercial gene therapy manufacturing milestone following US FDA’s approval of Ultragenyx’s Fayuvi to treat ...

Andelyn and its curator platform achieve first US FDA-approved commercial gene therapy manufacturing milestone following US FDA’s approval of Ultragenyx’s Fayuvi to treat Sanf ...
Pharmabiz

Karnataka FSDA initiates severe legal action on Bidadi medicine racket, cancels Pfizer license among others

Karnataka FSDA initiates severe legal action on Bidadi medicine racket, cancels Pfizer license among others: Our Bureau, Bengaluru Monday, September 21, 2026, 13:30 Hrs [IST] Karn ...
Pharmabiz

Masters’ Union University launches Kalam School of Bioscience

Masters’ Union University launched the Kalam School of Bioscience, a new school focused on bringing together biology, technology, engineering, healthcare and entrepreneurship as advances in genomics, ...
Pharmabiz

EMA committee recommends marketing approval for Novartis Cosentyx in polymyalgia rheumatica

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for ...